These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 380333)

  • 1. Familial herpes simplex infection associated with activation of the complement system.
    Kapadia A; Gupta S; Good RA; Day NK
    Am J Med; 1979 Jul; 67(1):122-6. PubMed ID: 380333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
    Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
    Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.
    Friedman HM; Wang L; Pangburn MK; Lambris JD; Lubinski J
    J Immunol; 2000 Oct; 165(8):4528-36. PubMed ID: 11035093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus infections in guinea pigs deficient in the fourth component of complement.
    Strunk RC; John TJ; Sieber OF
    Infect Immun; 1977 Jan; 15(1):165-8. PubMed ID: 188762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired C1-esterase inhibitor deficiency and recurrent herpes infection in a patient with chronic lymphocytic leukemia.
    Minh D; Czink E; Füst G; Hollán SR
    Diagn Immunol; 1983; 1(2):68-71. PubMed ID: 6680094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent bacterial meningitis due to genetic deficiencies of terminal complement components (C5 and C6).
    Haeney MR; Ball AP; Thompson RA
    Immunobiology; 1980; 158(1-2):101-6. PubMed ID: 7193645
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection.
    Verschoor A; Brockman MA; Gadjeva M; Knipe DM; Carroll MC
    J Immunol; 2003 Nov; 171(10):5363-71. PubMed ID: 14607939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity in Herpesvirus hominis infections.
    Wilton JM; Ivanyi L; Lehner T
    Br Med J; 1972 Mar; 1(5802):723-6. PubMed ID: 4552465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.
    Hook LM; Lubinski JM; Jiang M; Pangburn MK; Friedman HM
    J Virol; 2006 Apr; 80(8):4038-46. PubMed ID: 16571820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of hemolytic complement in the normal cornea.
    Mondino BJ; Brady KJ
    Arch Ophthalmol; 1981 Aug; 99(8):1430-3. PubMed ID: 7020664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inherited deficiency of the third component of complement, C3, in guinea pigs.
    Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
    Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response in genital herpes simplex virus infection.
    Corey L; Reeves WC; Holmes KK
    N Engl J Med; 1978 Nov; 299(18):986-91. PubMed ID: 211414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.
    Prober CG; Sullender WM; Yasukawa LL; Au DS; Yeager AS; Arvin AM
    N Engl J Med; 1987 Jan; 316(5):240-4. PubMed ID: 3025727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
    Fries LF; Friedman HM; Cohen GH; Eisenberg RJ; Hammer CH; Frank MM
    J Immunol; 1986 Sep; 137(5):1636-41. PubMed ID: 3018078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.
    Brockman MA; Knipe DM
    Vaccine; 2008 Dec; 26 Suppl 8(Suppl 8):I94-9. PubMed ID: 19388172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.